{"disease":{"id":"sarcoidosis-cardiac","name":"sarcoidosis cardiac"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03902223","title":"Routine Cardiac Screening in Sarcoidosis Patients","phase":"","overall_status":"COMPLETED","enrollment_count":1000,"lead_sponsor_name":"Foundation for Sarcoidosis Research","has_results":false},{"nct_id":"NCT03599414","title":"CASPA: CArdiac Sarcoidosis in PApworth","phase":"","overall_status":"COMPLETED","enrollment_count":104,"lead_sponsor_name":"Papworth Hospital NHS Foundation Trust","has_results":false},{"nct_id":"NCT05351554","title":"A Study to Assess the Safety, Tolerability, and Efficacy of Namilumab in Participants With Active Cardiac Sarcoidosis","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":1,"lead_sponsor_name":"Kinevant Sciences GmbH","has_results":true}],"total":3},"guidelines":[],"source":"Drug Landscape verified database"}